Neurology

The CGTLive Neurology specialty topic page houses video interviews with key opinion leaders in the field of neurology about the latest relevant FDA actions, clinical guideline updates, and clinical trial findings related to cell therapies, gene therapies, and engineered and regenerative medicines developed for neurologic disorders and diseases. It also contains up-to-date clinical news coverage in the field of gene and cell therapy for central nervous system disorders.

Latest News

CGTLive®’s Weekly Rewind
CGTLive®’s Weekly Rewind – July 11, 2025

July 11th 2025

Review top news and interview highlights from the week ending July 11, 2025.

Capricor’s BLA for DMD Cardiomyopathy Cell Therapy Deramiocel Slammed With CRL
Capricor’s BLA for DMD Cardiomyopathy Cell Therapy Deramiocel Slammed With CRL

July 11th 2025

Jeffrey Chamberlain, PhD, Professor, Neurology and Medical Genetics, and Adjunct Professor, Biochemistry, and McCaw Endowed Chair of Muscular Dystrophy at University of Washington
Jeffrey Chamberlain, PhD, on the Import of Early Intervention in DMD

July 10th 2025

Around the Helix: Cell and Gene Therapy Company Updates – July 9, 2025
Around the Helix: Cell and Gene Therapy Company Updates – July 9, 2025

July 9th 2025

Jeffrey Chamberlain, PhD, Professor, Neurology and Medical Genetics, and Adjunct Professor, Biochemistry, and McCaw Endowed Chair of Muscular Dystrophy at University of Washington
The Role of Gene Therapy for Patients with Duchenne Muscular Dystrophy

July 9th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.